Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 25, 2020	Sep. 27, 2019
Cash flows from operating activities:
Net earnings from continuing operations	$ 398.4	$ 546.6
Noncash items:
Depreciation	98.1	97.7
Amortization	254.5	211.4
Stock-based compensation expense	60.2	45.5
Impairment of goodwill	85.3	0.0
Gain from combination of business	0.0	(41.2)
Gain on sale of assets	(5.3)	0.0
Change in trade accounts receivable, net	147.8	(133.5)
Change in inventories	(10.2)	69.4
Change in trade accounts payable	13.4	(7.9)
Change in prepaid expenses and other assets	54.0	(115.1)
Change in accrued expenses and other liabilities	56.5	127.5
Total operating cash provided by continuing operations	1,152.7	800.4
Total operating cash used in discontinued operations	(0.8)	(4.4)
Net cash provided by operating activities	1,151.9	796.0
Cash flows from investing activities:
Payments for additions to property, plant and equipment	(86.2)	(79.6)
Proceeds from sale of assets	5.3	0.0
Cash paid for acquisitions, net of cash received	(24.7)	(3,387.7)
All other investing activities	0.5	0.0
Net cash used in investing activities	(105.1)	(3,467.3)
Cash flows from financing activities:
Net proceeds from (repayments of) commercial paper borrowings	(1,141.9)	695.5
Proceeds from borrowings (maturities longer than 90 days), net of issuance costs of $8 million and $24 million in 2020 and 2019, respectively	741.7	2,413.2
Repayment of borrowings (maturities greater than 90 days)	(250.0)	(455.3)
Payment of common stock cash dividend to shareholders	(70.7)	(70.3)
Payment of mandatory convertible preferred stock cash dividend to shareholders	(34.5)	(34.5)
All other financing activities	(4.8)	16.4
Net cash (used in) provided by financing activities	(760.2)	2,565.0
Effect of exchange rate changes on cash and equivalents	(2.7)	(11.6)
Net change in cash and equivalents	283.9	(117.9)
Beginning balance of cash and equivalents	1,205.2	1,178.4
Ending balance of cash and equivalents	$ 1,489.1	$ 1,060.5